Here’s why Eli Lilly is down heading into earnings — and how we plan to play it

Earnings

Articles You May Like

Pfizer says its experimental drug for deadly condition that causes appetite and weight loss in cancer patients shows positive trial results
Stocks making the biggest moves after hours: Adobe, RH, Oracle and more
China’s ultra-rich population sees ‘dramatic’ growth in last 10 years, outpacing the U.S., report shows
How Perfection Will Derail Your Retirement
China’s retail sales and industrial data miss expectations in August

Leave a Reply

Your email address will not be published. Required fields are marked *